Home

gevaarlijk Anders adopteren 6 diazo 5 oxo l norleucine Vervullen Onrustig rand

The glutamine antagonist 6-diazo-5-oxo-L-norleucine is the most... | Download Scientific Diagram
The glutamine antagonist 6-diazo-5-oxo-L-norleucine is the most... | Download Scientific Diagram

6-Diazo-5-oxo-L-norleucine | CAS 157-03-9 | SCBT - Santa Cruz Biotechnology
6-Diazo-5-oxo-L-norleucine | CAS 157-03-9 | SCBT - Santa Cruz Biotechnology

6-Diazo-5-oxo-L-norleucine - Wikipedia
6-Diazo-5-oxo-L-norleucine - Wikipedia

Chemical structure of 6-diazo-5-oxo-l-norleucine (DON) and the prodrug... | Download Scientific Diagram
Chemical structure of 6-diazo-5-oxo-l-norleucine (DON) and the prodrug... | Download Scientific Diagram

157-03-9・6-Diazo-5-oxo-L-norleucine・045-32441・041-32443[Detail Information] | [Life Science]|Laboratory Chemicals-FUJIFILM Wako Chemicals U.S.A. Corporation
157-03-9・6-Diazo-5-oxo-L-norleucine・045-32441・041-32443[Detail Information] | [Life Science]|Laboratory Chemicals-FUJIFILM Wako Chemicals U.S.A. Corporation

6-Diazo-5-oxo-L-norleucine | ≥99%(HPLC) | Selleck | Glutaminase 阻害剤
6-Diazo-5-oxo-L-norleucine | ≥99%(HPLC) | Selleck | Glutaminase 阻害剤

6-Diazo-5-oxo-L-norleucine - Chem-Impex International
6-Diazo-5-oxo-L-norleucine - Chem-Impex International

Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug | Science Advances
Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug | Science Advances

6-diazo-5-oxo-L-norleucine | C6H9N3O3 | CID 9087 - PubChem
6-diazo-5-oxo-L-norleucine | C6H9N3O3 | CID 9087 - PubChem

6-Diazo-5-oxo-L-norleucine, cr | D2141-5MG | SIGMA-ALDRICH | SLS
6-Diazo-5-oxo-L-norleucine, cr | D2141-5MG | SIGMA-ALDRICH | SLS

157-03-9 | 6-Diazo-5-oxo-L-norleucine | C₆H₉N₃O₃ | TRC
157-03-9 | 6-Diazo-5-oxo-L-norleucine | C₆H₉N₃O₃ | TRC

The combination of orlistat, lonidamine and 6‑diazo‑5‑oxo‑L‑norleucine induces a quiescent energetic phenotype and limits substrate flexibility in colon cancer cells
The combination of orlistat, lonidamine and 6‑diazo‑5‑oxo‑L‑norleucine induces a quiescent energetic phenotype and limits substrate flexibility in colon cancer cells

Sigma Aldrich Fine Chemicals Biosciences 6-Diazo-5-oxo-L-norleucine crystalline | Fisher Scientific
Sigma Aldrich Fine Chemicals Biosciences 6-Diazo-5-oxo-L-norleucine crystalline | Fisher Scientific

Protective Effects of Glutamine Antagonist 6-Diazo-5-Oxo-l-Norleucine in Mice with Alphavirus Encephalomyelitis | Journal of Virology
Protective Effects of Glutamine Antagonist 6-Diazo-5-Oxo-l-Norleucine in Mice with Alphavirus Encephalomyelitis | Journal of Virology

Tumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using Substituted Acetylated Lysine Prodrugs | Journal of Medicinal Chemistry
Tumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using Substituted Acetylated Lysine Prodrugs | Journal of Medicinal Chemistry

6-Diazo-5-oxo-L-norleucine for Sale from Quality Suppliers - ECHEMI
6-Diazo-5-oxo-L-norleucine for Sale from Quality Suppliers - ECHEMI

Bioanalysis of 6-diazo-5-oxo-l-norleucine in plasma and brain by ultra-performance liquid chromatography mass spectrometry
Bioanalysis of 6-diazo-5-oxo-l-norleucine in plasma and brain by ultra-performance liquid chromatography mass spectrometry

6-Diazo-5-oxo-L-norleucine-cancer research-TOKU-E
6-Diazo-5-oxo-L-norleucine-cancer research-TOKU-E

GMP Synthase Is Required for Virulence Factor Production and Infection by Cryptococcus neoformans*
GMP Synthase Is Required for Virulence Factor Production and Infection by Cryptococcus neoformans*

6-Diazo-5-oxo-L-norleucine | C6H9N3O3 | ChemSpider
6-Diazo-5-oxo-L-norleucine | C6H9N3O3 | ChemSpider

WO2016112386A1 - Methods for bioanalysis of 6-diazo-5-oxo-l-norleucine (don) and other glutamine antagonists - Google Patents
WO2016112386A1 - Methods for bioanalysis of 6-diazo-5-oxo-l-norleucine (don) and other glutamine antagonists - Google Patents

File:6-diazo-5-oxo-L-norleucine.png - Wikimedia Commons
File:6-diazo-5-oxo-L-norleucine.png - Wikimedia Commons

Tumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using Substituted Acetylated Lysine Prodrugs | Journal of Medicinal Chemistry
Tumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using Substituted Acetylated Lysine Prodrugs | Journal of Medicinal Chemistry

Structure of 6-diazo-5-oxo-norleucine-bound human gamma-glutamyl transpeptidase 1, a novel mechanism of inactivation
Structure of 6-diazo-5-oxo-norleucine-bound human gamma-glutamyl transpeptidase 1, a novel mechanism of inactivation